Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations for small intestinal delivery of RSV and norovirus antigens

Formulations for small intestinal delivery of RSV and norovirus antigens

US Patent 11433146 · Granted Sep 6, 2022

Estimated economic value: $6,015,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations for small intestinal delivery of RSV and norovirus antigens2025
Formulations for small intestinal delivery of RSV and norovirus antigens2025
Formulations for small intestinal delivery of RSV and norovirus antigens2025
Formulations for small intestinal delivery of RSV and norovirus antigens2025
Alphavirus neoantigen vectors2024
Modified adenoviruses2024
Multiepitope vaccine cassettes2023
Modified adenoviruses2023
Alphavirus antigen vectors2022
Alphavirus neoantigen vectors2022
Device and apparatus for collecting microbial growth from a semi-solid surface2021
Chimeric adenoviral vectors2015